Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580827 · ClinicalTrials.gov registry record · NA
Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers
A NA study of Opiate Dependence and Cocaine-Related Disorder, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
- 1
- Study location
NCT00580827 is a NA study of Opiate Dependence and Cocaine-Related Disorder that has completed, run by Yale University. The registered enrollment target is 126 participants, below the 599-participant average among 15 other Opiate Dependence trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00580827, a NA study of Opiate Dependence and Cocaine-Related Disorder, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
This 18-week, randomized, double blind clinical trial provided treatment for 160 cocaine-dependent opioid addicts, aged 18-65 years. Participants were stabilized on LAAM maintenance during the first 4 weeks and cocaine use was assessed; participants were then stratified by level of cocaine use and randomly assigned to receive one of the following: placebo disulfiram (0 mg/day), disulfiram at 62.5 mg/day, disulfiram at 125 mg/day, or disulfiram at 250 mg/day. During induction onto LAAM, participants were administered increasing doses of LAAM plus placebo disulfiram on a thrice-weekly basis until maintenance doses of LAAM are attained. At the beginning of week 5, participants received LAAM plus disulfiram or placebo disulfiram according to their randomized assignments, and were maintained on these agents through week 16. At the end of the study, participants underwent detoxification from LAAM and active/placebo medication over a 4- to 6-week period. All participants received weekly 1-hour psychotherapy (Cognitive Behavioral Treatment) with experienced clinicians specifically trained to deliver the therapy and who received ongoing supervision. The primary outcomes were retention and reduction in opioid and cocaine use, as assessed by self-report and confirmed by thrice-weekly urinalyses. Secondary outcomes included reductions in other illicit drug and alcohol use, as well as improvements in psychosocial functioning.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Disulfiram
Study Locations (1)
Connecticut
- West Haven VA - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2003-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580827
The ClinicalTrials.gov registry entry for NCT00580827 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 599-participant average among 15 other Opiate Dependence trials with a reported enrollment target (79% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Opiate Dependence appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00580827 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00580827 about?
NCT00580827 is a clinical study titled "Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers". This 18-week, randomized, double blind clinical trial provided treatment for 160 cocaine-dependent opioid addicts, aged 18-65 years. Participants were stabilized on LAAM maintenance during the first 4 weeks and cocaine use was assessed; participants were then stratified by level of cocaine use and r...
What is the current status of trial NCT00580827?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2003-09.
What conditions does trial NCT00580827 study?
This clinical trial studies the following conditions: Opiate Dependence, Cocaine-Related Disorder.
What interventions are being tested in trial NCT00580827?
The interventions under investigation include: Placebo (DRUG), Disulfiram (DRUG).
Who is sponsoring clinical trial NCT00580827?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00580827 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opiate Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain
COMPLETED · NA
-
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
COMPLETED · NA
-
Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting
COMPLETED · NA
-
Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment
COMPLETED · NA
-
Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET
COMPLETED · NA
-
Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.